{"DataElement":{"publicId":"2006678","version":"1","preferredName":"Cancer type other, please specify","preferredDefinition":"Free text field to describe the anatomic location of malignancy or type of diagnosed cancer","longName":"CANCER_TYPE_OTHR","context":"SPOREs","contextVersion":"2.31","DataElementConcept":{"publicId":"2014474","version":"1","preferredName":"Cancer Diagnosis Type","preferredDefinition":"Identification of a type of cancer by the signs, symptoms, and anatomic location..","longName":"CA_DX_TP","context":"SPOREs","contextVersion":"2.31","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2516523","version":"1","preferredName":"Diagnosis Type","preferredDefinition":"The process of identifying a disease by the signs and symptoms.:Type; a subdivision of a particular kind of thing.","longName":"C15220:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C116696-5AC3-66FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-28","modifiedBy":"ONEDATA","dateModified":"2006-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8241063-1A8A-3B85-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-05","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018779","version":"1","preferredName":"Cancer Type Other","preferredDefinition":"Free text field to describe the anatomic location of malignancy or type of previously diagnosed cancer.","longName":"CANCER_TYPE_OTHER","context":"SPOREs","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2735616","version":"1","preferredName":"Malignant Neoplasm Other Text","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:Not otherwise specified.:Text; the words of something written.","longName":"C9305:C17649:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48913A72-B70D-67F7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-16","modifiedBy":"ONEDATA","dateModified":"2008-03-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8242ECD-4214-3B55-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-05","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-05","modifiedBy":"REEVESD","dateModified":"2008-03-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2180156","version":"1","longName":"New CDEs per study","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2811713","version":"1","longName":"Iloprost 01279","context":"SPOREs"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2812155","version":"1","longName":"Sporadic Colorectal Neoplasia - Atrovastatin","context":"DCP"},{"publicId":"2812154","version":"1","longName":"Bronchial Dysplasia - Sulindac","context":"DCP"},{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"},{"publicId":"2813064","version":"1","longName":"Erlotinib - Lesions of Lung","context":"DCP"}]},{"publicId":"2931931","version":"1","longName":"Iloprost Trial","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2931952","version":"1","longName":"Iloprost 12079","context":"SPOREs"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5441476","version":"1","longName":"MDA2014-04-02","context":"DCP"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"PS&CC","type":"USED_BY","context":"PS-CC"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"CHSINIDX_DXOTSP","type":"OID, AMC","context":"AMC"},{"name":"CHSRCNTDX _DXOTSP","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Cancer type other, please spe","type":"Preferred Question Text","description":"Cancer type other, please specify","url":null,"context":"SPOREs"},{"name":"CRF TEXT","type":"Alternate Question Text","description":"Specif type of Cancer","url":null,"context":"SPOREs"},{"name":"DCP Document Text 2","type":"Alternate Question Text","description":"Cancer","url":null,"context":"DCP"},{"name":"DCP Document Text","type":"Alternate Question Text","description":"If Other type of cancer, Specify","url":null,"context":"DCP"},{"name":"DCP Document Text 3","type":"Alternate Question Text","description":"If other/additional type of cancer, please specify","url":null,"context":"DCP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Cancer type, specify","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Cancer type, specify:","url":null,"context":"COG"},{"name":"DCP-Text-4","type":"Alternate Question Text","description":"If Yes, Cancer type(s)","url":null,"context":"DCP"},{"name":"DCP-Text-5","type":"Alternate Question Text","description":"Cancer Type","url":null,"context":"DCP"},{"name":"AMC CRF Text 1","type":"Alternate Question Text","description":"Specify","url":null,"context":"AMC"},{"name":"DCP TEXT 6","type":"Alternate Question Text","description":"Cancer Type(s)","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B823A742-D05E-3DB0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-05","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-05","modifiedBy":"MMADDINENI","dateModified":"2023-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}